Is There More Upside Ahead For Abbott Laboratories (NYSE: ABT)
Abbott Laboratories (ABT) concluded trading on Thursday at a closing price of $133.17, with 5.04 million shares of worth about $671.66 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 19.01% during that period and on February 20, 2025 the price saw a gain […]
Abbott Laboratories (ABT) Testing Investors’ Patience Right Now
Currently, there are 1.73B common shares owned by the public and among those 1.72B shares have been available to trade. The company’s stock has a 5-day price change of 1.81% and 14.00% over the past three months. ABT shares are trading 16.21% year to date (YTD), with the 12-month market performance up to 16.91% higher. […]
Abbott Laboratories (NYSE: ABT) Hogging The Spotlight Today
Currently, there are 1.73B common shares owned by the public and among those 1.72B shares have been available to trade. The company’s stock has a 5-day price change of 1.34% and 13.87% over the past three months. ABT shares are trading 14.14% year to date (YTD), with the 12-month market performance up to 12.76% higher. […]
Growing Through Challenges? – Abbott Laboratories (ABT)
Currently, there are 1.73B common shares owned by the public and among those 1.72B shares have been available to trade. The company’s stock has a 5-day price change of 14.06% and 10.61% over the past three months. ABT shares are trading 14.43% year to date (YTD), with the 12-month market performance up to 16.85% higher. […]
Value Hunters: Look To Abbott Laboratories (ABT)
Currently, there are 1.73B common shares owned by the public and among those 1.72B shares have been available to trade. The company’s stock has a 5-day price change of 3.18% and -0.93% over the past three months. ABT shares are trading 3.25% year to date (YTD), with the 12-month market performance up to 2.43% higher. […]
Abbott Laboratories (ABT): Not A Time To Panic Nor Freeze
Abbott Laboratories (ABT) concluded trading on Wednesday at a closing price of $111.10, with 6.54 million shares of worth about $726.38 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 8.16% during that period and on January 15, 2025 the price saw a loss […]
Value Hunters: Look To Abbott Laboratories (ABT)
Currently, there are 1.73B common shares owned by the public and among those 1.72B shares have been available to trade. Insiders at the company have transacted a total of 73 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 20 of these insider trades were purchases, […]
An Important Check-Up On Abbott Laboratories (NYSE: ABT)
Abbott Laboratories (ABT) concluded trading on Wednesday at a closing price of $112.06, with 3.99 million shares of worth about $447.23 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 6.78% during that period and on Wednesday the price saw a gain of about […]
Abbott Laboratories (NYSE: ABT): Stock That Needs Special Handling
Currently, there are 1.74B common shares owned by the public and among those 1.72B shares have been available to trade. Insiders at the company have transacted a total of 94 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 39 of these insider trades were purchases, […]
Abbott Laboratories (ABT) Testing Investors’ Patience Right Now
BlackRock Fund Advisors recently announced the acquisition of new stake in Abbott Laboratories (NYSE:ABT). The institutional investor has increased its shareholding in the Healthcare company by 1.96% to 89.35 million shares with purchase of 1.72 million shares. This fresh investment now brings its stake to 5.15% valued currently at $9.83 billion. In addition, Capital Research […]
